Join leaders in the AI-Driven Drug Discovery market for a fireside chat exploring how to build the next-generation of digital biotech. BigHat Biosciences, Terray Therapeutics and AWS discuss topics including company building, science fact vs. fiction and the future of medicine. Understand how the intersection of biology and chemistry is enabling new techniques to develop novel therapeutics through the lens of technology. Walk away with insights from startup founders about building and running a startup that are applicable across all industries.
Jacob Berlin | Chief Executive Officer, Terray
Jacob is a distinguished inventor at the intersection of nanotechnology and synthetic chemistry. Prior to joining Terray full-time, he ran an NIH-funded lab at City of Hope, where he was an associate professor. He has more than 40 publications, 20 patents and over 11 thousand citations associated with his work. He was named one of the “Rising Stars and Young Nanoarchitects in Materials Science” by the Royal Society of Chemistry and was nominated for the Kabiller Young Investigator Award in Nanoscience and Nanomedicine. Jacob received his PhD in organometallic chemistry from CalTech where he studied with Nobel Laureate Bob Grubbs. Jacob completed his postdoctoral training at MIT and Rice University focusing on synthetic chemistry and nanotechnology, and received a BA in chemistry from Harvard University (magna cum laude).
Peyton Greenside | CSO & Cofounder, BigHat
A pioneer of deep learning applied to life science problems, Peyton has developed computational, statistical, and AI/ML techniques to model, understand, and optimize biological sequences in academia and industry. Peyton was an inaugural Schmidt Science Fellow, a computational biologist at the Broad Institute, a scientific founder of Valis, and holds a PhD from Stanford University (Accel Innovation Scholar), an MPhil in Computational Biology from Cambridge University (Herchel Smith Scholar), and a BA in Applied Math from Harvard
Eric Zimmerman | Principal, Healthcare & Life Sciences, Amazon Web Services, AWS
Eric Zimmerman is part of the startup and venture capital business development team at Amazon Web Services (AWS) focusing on healthcare and life sciences. He also works in product management for open source, pre-competitive tools to make conducting science on AWS easier. Prior to AWS, Eric was a venture capitalist investing in biotech and healthcare companies.